Do probiotics have an effect on healthy adults? It's too early to tell

May 9, 2016

There is little evidence to support any consistent effect of probiotics on the gut microbiota of healthy individuals, according to a systematic review published in the open access journal Genome Medicine. The World Health Organization defines probiotics as live microorganisms which confer a health benefit to the host if administered in adequate amounts and probiotics products are often marketed toward the general population. However, evidence for their effects on bacteria living in the guts of healthy adults remains elusive.

The study by researchers at the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen is a of seven randomized controlled trials (RCTs) investigating the effect of probiotic products on the fecal microbiota of healthy adults.

Nadja Buus Kristensen, PhD student and junior author, said: "According to our systematic review, no convincing evidence exists for consistent effects of examined probiotics on fecal microbiota composition in healthy adults, despite probiotic products being consumed to a large extent by the ."

"A systematic review of experimental evidence allows us to pull together evidence and look at the relationship between probiotic products and the composition of the fecal microbiota in healthy people using explicit, systematic methods, ensuring the highest level of evidence," she said.

The researchers investigated RCTs for reported effects of probiotics on the overall structure of the fecal microbiota of healthy adults, including the number of species present, the evenness (distribution of species within the populations) and whether the probiotics groups of study participants as a result of the intervention had different changes in bacteria living in their gut than the placebo groups.

The authors found that of the seven original RCTs included in the study, only one observed significantly greater changes in the bacterial species composition of the fecal microbiota in individuals who consumed probiotics compared to those who did not.

Previous research has suggested an unbalancing effect of common disorders like obesity, diabetes, or colorectal cancer on the fecal microbiota and the therapeutic effects of probiotics have been studied in many diseases. Yet, while evidence of their effectiveness in metabolic and gastrointestinal disorders can be measured for example against body mass index, insulin resistance or the severity of gastrointestinal symptoms, measuring the effect of probiotics in healthy individuals is more difficult, according to the authors. Also, an international consensus on what defines a normal or healthy fecal microbial community is lacking.

To identify studies for inclusion in their systematic review, the authors conducted a literature search across three citation indices - PubMed, SCOPUS and ISI Web of Science. Studies were included based on study population (healthy adults), study design (RCT), means of intervention (probiotics or placebo), and intervention outcome (changes in the composition of the fecal microbiota). Studies were excluded if they were not RCTs, if they examined only effects within one group of individuals without comparing them to another, if they combined probiotics with other interventions or if they examined both healthy and unhealthy individuals.

Study participants across the seven original RCTs included in this review were healthy adults between 19 and 88 years of age. Numbers of individuals ranged from 21 to 81 and the proportion of women was between 50 and 100%. Probiotic products were administered as biscuits, milk-based drinks, sachets, or capsules for periods of 21 to 42 days.

The authors note that small sample sizes, variation in susceptibility to the probiotics between individual participants, use of different probiotic strains either in isolation or in combination and variations between the diets of individuals included in various study groups may have masked the true impact of probiotic intake.

Oluf Pedersen, professor at the University of Copenhagen and senior author of the paper said: "While there is some evidence from previous reviews that probiotic interventions may benefit those with disease-associated imbalances of the , there is little evidence of an effect in healthy individuals. To explore the potential of probiotics to contribute to disease prevention in healthy people there is a major need for much larger, carefully designed and carefully conducted clinical trials. These should include ideal composition and dosage of known and newly developed combined with specified dietary advice, optimal trial duration and relevant monitoring of host health status."

Explore further: Impact on gut microbiota of a fermented milk product containing probiotics

More information: Nadja B. Kristensen et al, Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials, Genome Medicine (2016). DOI: 10.1186/s13073-016-0300-5

Related Stories

Impact on gut microbiota of a fermented milk product containing probiotics

September 12, 2014
Scientists from INRA and Danone Nutricia Research have shown the effect of a fermented milk product containing probiotics on the gut microbiota, using a novel high resolution bioinformatics tool. The product affected certain ...

Probiotics associated with reduced risk of diarrhea from antibiotic use: study

May 8, 2012
Consumption of probiotics (live microorganisms, which may occur naturally in foods such as yogurt, intended to confer a health benefit when consumed) is associated with a reduced risk of antibiotic-associated diarrhea, a ...

Probiotics mitigate stress in medical students at exam time

May 9, 2016
A probiotic given to medical students during the run-up to nationwide medical school examinations reduced stress among the students. "The probiotic strain, Lactobacillus casei strain Shirota can relieve many aspects of the ...

Probiotics protect mice from estrogen deficiency-related bone loss

April 25, 2016
After menopause, a decline in estrogen levels is linked to increases in inflammation that can cause osteoporosis. Intestinal bacteria have been shown to influence inflammation by modulating immune responses, and a new study ...

Probiotics and the gut-brain axis

October 14, 2015
A recent study published in Brain, Behavior, and Immunity has found that intake of multispecies probiotics has a beneficial effect on cognitive reactivity to sad mood in a randomized controlled trial.

Recommended for you

Forgotten strands of DNA initiate the development of immune cells

September 21, 2017
Intricate human physiological features such as the immune system require exquisite formation and timing to develop properly. Genetic elements must be activated at just the right moment, across vast distances of genomic space.

Genome editing reveals role of gene important for human embryo development

September 20, 2017
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development. This is the first time that genome editing has been used to study gene function in human ...

A piece of the puzzle: Eight autism-related mutations in one gene

September 19, 2017
Scientists have identified a hotspot for autism-related mutations in a single gene.

Scientists identify key regulator of male fertility

September 19, 2017
When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.

New assay leads to step toward gene therapy for deaf patients

September 18, 2017
Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

Genomic recycling: Ancestral genes take on new roles

September 18, 2017
One often hears about the multitude of genes we have in common with chimps, birds or other living creatures, but such comparisons are sometimes misleading. The shared percentage usually refers only to genes that encode instructions ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

checksinthemail
5 / 5 (1) May 09, 2016
What's interesting is reading a cautionary article like this, and seeing the linked related/recommended stories which show benefit in healthy individuals.
Telekinetic
5 / 5 (1) May 10, 2016
This is more Pharma propaganda that insults the public's intelligence, but then again the public is enamored with Trump. Any healthy individual who occasionally uses antibiotics will of course benefit his health and his microbiome by repopulating it with probiotics after the course of antibiotics. I personally avoid antibiotics and take probiotics like L-Reuteri and Saccharomyces Boulardii because clinical studies from NCBI, a government- funded medical research lab corroborates its efficacy. The pharmaceutical companies like Bayer were operating in Nazi Germany using slave labor and human guinea pigs. Of course all of the executives wound up over here after the war.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.